In This Section

Program

Please note that this meeting will take place as an in-person event in Denver and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the registration page for details.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

[R] – Remote Presentation

FRIDAY, MAY 21

SATURDAY, MAY 22

SUNDAY, MAY 23

Friday, May 21

REGISTRATION

4-8 p.m.

Plenary Session 1: Radiotherapy and the Microbiome

6-8 p.m.

  • When gut dysbiosis compromises thymic health
    Laurence Zitzvogel, Gustave-Roussy Cancer Campus, Villejuif, France
  • Lactic acid producing bacteria in the tumor microenvironment
    Lauren Colbert, Duke University, Durham, North Carolina

Panel Discussion

7-8 p.m.

Saturday, May 22

Continental Breakfast

7-8 a.m.

Plenary Session 2: Radiotherapy and Tumor Metabolism

8-10 a.m.

  • The intersection of serine metabolism with tumor radioresistance and normal tissue responses to radiation
    Erina Vlashi, University of California, Los Angeles, California
  • Optimizing radiation therapy by targeting tumor metabolism
    Julie Schwarz, Washington University, St. Louis, Missouri
  • David Gius, University of Cincinnati Cancer Center, Cincinnati, Ohio

Short talks selected from proffered abstracts

Break

10-10:15 a.m.

Plenary Session 3: Relationship between Radiation Therapy and Senescence

10:15-11:45 a.m.

  • 10:15 a.m. | Thomas Walle, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • 10:45 a.m. | Deb Citrin, National Cancer Center, Bethesda, Maryland

Short talks selected from proffered abstracts

Lunch on Own / Free Time

11:45 a.m.-1:15 p.m.

Plenary Session 4: Radiobiology of Heterogenous Dose Rate and Distribution

1:15-2:45 p.m.

  • Moving Beyond Dose: Why dose topology matters in radiotherapy
    Yolando Prezado, Center for Research in Molecular Medicine and Chronic Disease, Barcelona
  • Katherine A. Vallis, University of Oxford, Oxford, United Kingdom

Short talks selected from proffered abstracts

Break

3:15-3:30 p.m.

Plenary Session 5: Immune Signaling and Radiation

3:30-5 p.m.

  •  Silvia C. Formenti, Weill Cornell Medicine, New York, New York
  • Pattern recognition receptor network in response to ionizing radiation
    Shane Harding, University of Toronto, Toronto, Ontario, Canada

Short talks selected from proffered abstracts

Break

5-5:15 p.m.

Plenary Session 6: Tumor Microenvironment and Radiation Response

5:15-6:15 p.m.

  • Reprogramming tissue tolerance to unleash radiation-induced antitumor immunity
    Nir Ben Chetrit, Weill Cornell Medicine, New York, New York
  • Neurotransmitter‑mediated crosstalk regulates glioblastoma radiosensitivity
    Kelli Pointer, Dartmouth Cancer Center, Lebanon, New Hampshire

Short talks selected from proffered abstracts

Panel Discussion—From Damage to Defense: Host Response to Radiation and Immunotherapy

6:15-7 p.m.

Poster Session / Reception

7:15-9 p.m.

Sunday, May 23

Continental Breakfast

7-8 a.m.

Plenary Session 7: Epigenetic Reprogramming and Radiotherapy

8-9:30 a.m.

  • Fei-Fei Liu, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada
  • Epigenetic Reprogramming of the DNA damage response and the efficacy of radiotherapy in gliomas
    Maria Castro, University of Michigan, Michigan

Short talks selected from proffered abstracts

Break

9-9:30 a.m.

Plenary Session 8: To be Developed by the Radiation Science and Medicine Working Group

9:30-11 a.m.

Break

11-11:15 a.m.

Plenary Session 9: From Molecules to Models: Signaling Through Multi-Omics

11:15 a.m.-12:15 p.m.

  • Joe Deasy, Memorial Sloan Kettering Cancer Center, New York, New York

Additional speakers to be announced
Short talks selected from proffered abstracts

Departure

12:15 p.m.